During the past decade, Accellacare (formerly PMG Research of Wilmington, LLC) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Accellacare (formerly PMG Research of Wilmington, LLC)" #1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Accellacare (formerly PMG Research of Wilmington, LLC)" are "COVID-19" (2 trials) and "SARS-CoV-2 Infection" (2 trials). Many other conditions were trialed in "Accellacare (formerly PMG Research of Wilmington, LLC)" in a lesser frequency.

Most popular intervention types in "Accellacare (formerly PMG Research of Wilmington, LLC)" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BNT162b2" (2 trials), "BNT162b2 OMI" (1 trials), "Combination (Bivalent) BNT162b2 and BNT162b2 OMI" (1 trials), "Combination BNT162b2 and BNT162b2 OMI" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Accellacare (formerly PMG Research of Wilmington, LLC)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Accellacare (formerly PMG Research of Wilmington, LLC)". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Accellacare (formerly PMG Research of Wilmington, LLC), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Accellacare (formerly PMG Research of Wilmington, LLC), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".